Article
The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies
9 Mar 2023
Abstract excerpt
Soft tissue sarcomas (STS) are a rare, complex, heterogeneous group of mesenchymal neoplasms with over 150 different histological subtypes. Treatments for this malignancy have been especially challenging due to the heterogeneity of the disease and the modest efficacy of conventional chemotherapy. The next frontier lies in discerning the molecular pathways in which these mesenchymal neoplasms arise, metastasize,...
Topics
Join the communities discussing this publication.